|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Malvezzi M, Bertuccio P, Rosso T, Rota M,
Levi F, La Vecchia C and Negri E: European cancer mortality
predictions for the year 2015: Does lung cancer have the highest
death rate in EU women? Ann Oncol. 26:779–786. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Okuda T and Kondoh H: Identification of
new genes ndr2 and ndr3 which are related to Ndr1/RTP/Drg1 but show
distinct tissue specificity and response to N-myc. Biochem Biophys
Res Commun. 266:208–215. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Han LL, Hou L, Zhou MJ, Ma ZL, Lin DL, Wu
L and Ge YL: Aberrant NDRG1 methylation associated with its
decreased expression and clinicopathological significance in breast
cancer. J Biomed Sci. 20:522013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kovacevic Z, Fu D and Richardson DR: The
iron-regulated metastasis suppressor, Ndrg-1: Identification of
novel molecular targets. Biochim Biophys Acta. 1783:1981–1992.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Angst E, Dawson DW, Nguyen A, Park J, Go
VL, Reber HA, Hines OJ and Eibl G: Epigenetic regulation affects
N-myc downstream-regulated gene 1 expression indirectly in
pancreatic cancer cells. Pancreas. 39:675–679. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim-Fuchs C, Winterhalder S, Winter A,
Malinka T, Born D, Schäfer S, Stroka D, Gloor B, Candinas D and
Angst E: The silencing of N-myc downstream-regulated gene-1 in an
orthotopic pancreatic cancer model leads to more aggressive tumor
growth and metastases. Dig Surg. 31:135–142. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Youns M and Fathy GM: Upregulation of
extrinsic apoptotic pathway in curcumin-mediated antiproliferative
effect on human pancreatic carcinogenesis. J Cell Biochem.
114:2654–2665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang X, Zhang S, Ma J, Li Z, Zhi Y, Chen
J, Lu Y and Dai D: Association of NDRG1 gene promoter methylation
with reduced NDRG1 expression in gastric cancer cells and tissue
specimens. Cell Biochem Biophys. 66:93–101. 2013. View Article : Google Scholar
|
|
10
|
Li Q and Chen H: Transcriptional silencing
of N-Myc downstream-regulated gene 1 (NDRG1) in metastatic colon
cancer cell line SW620. Clin Exp Metastasis. 28:127–135. 2011.
View Article : Google Scholar
|
|
11
|
Geng XX, Quan LN, Ma R and Tang LP:
Effects of As2O3 and all-trans retinoic acid
on the growth of HeLa cell line and their relation with gene NDRG1.
Zhonghua Zhong Liu Za Zhi. 33:8–12. 2011.(In Chinese). PubMed/NCBI
|
|
12
|
Hosoya N, Sakumoto M, Nakamura Y, Narisawa
T, Bilim V, Motoyama T, Tomita Y and Kondo T: Proteomics identified
nuclear N-myc downstream-regulated gene 1 as a prognostic tissue
biomarker candidate in renal cell carcinoma. Biochim Biophys Acta.
1834:2630–2639. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dixon KM, Lui GY, Kovacevic Z, Zhang D,
Yao M, Chen Z, Dong Q, Assinder SJ and Richardson DR: Dp44mT
targets the AKT, TGF-β and ERK pathways via the metastasis
suppressor NDRG1 in normal prostate epithelial cells and prostate
cancer cells. Br J Cancer. 108:409–419. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu W, Iiizumi-Gairani M, Okuda H,
Kobayashi A, Watabe M, Pai SK, Pandey PR, Xing F, Fukuda K, Modur
V, et al: KAI1 gene is engaged in NDRG1 gene-mediated metastasis
suppression through the ATF3-NFkappaB complex in human prostate
cancer. J Biol Chem. 286:18949–18959. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ghalayini MK, Dong Q, Richardson DR and
Assinder SJ: Proteolytic cleavage and truncation of NDRG1 in human
prostate cancer cells, but not normal prostate epithelial cells.
Biosci Rep. 33:332013. View Article : Google Scholar
|
|
16
|
Symes AJ, Eilertsen M, Millar M, Nariculam
J, Freeman A, Notara M, Feneley MR, Patel HR, Masters JR and Ahmed
A: Quantitative analysis of BTF3, HINT1, NDRG1 and ODC1 protein
over-expression in human prostate cancer tissue. PLoS One.
8:e842952013. View Article : Google Scholar
|
|
17
|
Lee JC, Chung LC, Chen YJ, Feng TH and
Juang HH: N-myc downstream-regulated gene 1 downregulates cell
proliferation, invasiveness, and tumorigenesis in human oral
squamous cell carcinoma. Cancer Lett. 355:242–252. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kovacevic Z, Sivagurunathan S, Mangs H,
Chikhani S, Zhang D and Richardson DR: The metastasis suppressor,
N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via
p53-independent mechanisms. Carcinogenesis. 32:732–740. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hosoi F, Izumi H, Kawahara A, Murakami Y,
Kinoshita H, Kage M, Nishio K, Kohno K, Kuwano M and Ono M: N-myc
downstream regulated gene 1/Cap43 suppresses tumor growth and
angiogenesis of pancreatic cancer through attenuation of inhibitor
of kappaB kinase beta expression. Cancer Res. 69:4983–4991. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Holliday R: The inheritance of epigenetic
defects. Science. 238:163–170. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ushijima T: Detection and interpretation
of altered methylation patterns in cancer cells. Nat Rev Cancer.
5:223–231. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cottrell SE: Molecular diagnostic
applications of DNA methylation technology. Clin Biochem.
37:595–604. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Esteller M, Corn PG, Baylin SB and Herman
JG: A gene hypermethylation profile of human cancer. Cancer Res.
61:3225–3229. 2001.PubMed/NCBI
|
|
24
|
Yang B, Guo M, Herman JG and Clark DP:
Aberrant promoter methylation profiles of tumor suppressor genes in
hepatocellular carcinoma. Am J Pathol. 163:1101–1107. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Edamoto Y, Hara A, Biernat W, Terracciano
L, Cathomas G, Riehle HM, Matsuda M, Fujii H, Scoazec JY and Ohgaki
H: Alterations of RB1, p53 and Wnt pathways in hepatocellular
carcinomas associated with hepatitis C, hepatitis B and alcoholic
liver cirrhosis. Int J Cancer. 106:334–341. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kalaydjieva L, Gresham D, Gooding R,
Heather L, Baas F, de Jonge R, Blechschmidt K, Angelicheva D,
Chandler D, Worsley P, et al: N-myc downstream-regulated gene 1 is
mutated in hereditary motor and sensory neuropathy-Lom. Am J Hum
Genet. 67:47–58. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM and
Pardee AB: Drg-1 as a differentiation-related, putative metastatic
suppressor gene in human colon cancer. Cancer Res. 60:749–755.
2000.PubMed/NCBI
|
|
28
|
Gravina GL, Ranieri G, Muzi P, Marampon F,
Mancini A, Di Pasquale B, Di Clemente L, Dolo V, D'Alessandro AM
and Festuccia C: Increased levels of DNA methyltransferases are
associated with the tumorigenic capacity of prostate cancer cells.
Oncol Rep. 29:1189–1195. 2013.
|
|
29
|
Gillio-Tos A, Fiano V, Zugna D, Vizzini L,
Pearce N, Delsedime L, Merletti F and Richiardi L: DNA
methyltransferase 3b (DNMT3b), tumor tissue DNA methylation,
Gleason score, and prostate cancer mortality: Investigating causal
relationships. Cancer Causes Control. 23:1549–1555. 2012.
View Article : Google Scholar : PubMed/NCBI
|
